Complete Genome Sequence of the Collinolactone Producer Streptomyces sp. Strain Gö40/10

The actinomycete Streptomyces sp. strain Gö40/10 has the potential to produce a range of secondary metabolites, one of which is collinolactone, a compound with neuroprotective properties and potential for pharmaceutical applications. The genome was sequenced with Oxford Nanopore Technologies MinION...

Full description

Saved in:
Bibliographic Details
Published inMicrobiology resource announcements Vol. 11; no. 8; p. e0022022
Main Authors Sterndorff, Eva B., Jørgensen, Tue S., Garzón, Jaime Felipe Guerrero, Schmid, Julian, Grond, Stephanie, Weber, Tilmann
Format Journal Article
LanguageEnglish
Published 1752 N St., N.W., Washington, DC American Society for Microbiology 27.07.2022
Subjects
Applied and Industrial Microbiology
Genome Sequences
Online AccessGet full text

Cover

More Information
Summary:The actinomycete Streptomyces sp. strain Gö40/10 has the potential to produce a range of secondary metabolites, one of which is collinolactone, a compound with neuroprotective properties and potential for pharmaceutical applications. The genome was sequenced with Oxford Nanopore Technologies MinION and Illumina MiSeq systems and consists of a single 9,635,564-nucleotide linear chromosome.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
The authors declare no conflict of interest.
ISSN:2576-098X
2576-098X
DOI:10.1128/mra.00220-22